DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: End Brain Cancer Initiative

June 2, 2023
EBCI To Attend ASCO 2023

EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide.

Read More
October 13, 2022
Making a Difference in Healthcare

Dellann Elliott Mydland, President & Board Chair, End Brain Cancer Initiative (EBCI), is a dynamic competitor due to her experience taking down brain tumors, brain cancer, and metastasized disease to the brain. Read her new article in The Corporate Magazine.

Read More
August 11, 2022
Founder Dellann Speaks About The Last 20 Years At EBCI w/NW News Radio

Last month, our founder, Dellann, had an amazing discussion with host of Puget Sound Now, Bill Swartz to discuss a bit of EBCI' story.

Read More
August 4, 2022
EBCI’s Bookshop is Now Open

Visit the online EBCI bookshop to purchase from a curated list of books on brain tumors, support, cancer personal stories and much more.

Read More
August 1, 2022
CALL TO ACTION:
INCREASE CAPACITY & SUSTAINABILITY

To create increased impact in the health and research industries and to help us reach our goal of growing to a $2M 501 (c)3 non-profit social enterprise organization, we are expanding our board of directors and are seeking new members.

Read More
March 29, 2022
If The #’s Don’t Make Sense, The DREAM Has To…

This year is all about the reality of running a 501(c)3 non-profit Advocacy organization from my perspective that directly and head-on meets the large unmet needs of patients, caregivers and their family members after a GBM diagnosis.

Read More
March 28, 2022
LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission.

Read More
March 11, 2022
CELEBRATING 20 YEARS: End Brain Cancer Initiative Seeking ACTIVE Board Members and Large Donors to Help Us Move from a Board of Staff to a Board of Governors for Increased Impact

Mission: to enhance cancer patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, neuro-surgeons, advanced & innovative treatments, and clinical trials.

Read More
February 28, 2022
“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

This month’s CURE MAG Cover Tip brought to you by the End Brain Cancer Initiative,  and through our patient advocacy and disease education partnership with CURE, focuses on Glioblastoma Multiforme (GBM).

Read More
May 31, 2020
Today Would Have Been our 2020 Bellingham Brain Cancer Walk….

Today, May 31, 2020, the very last day of #BTAM month, I find myself reflecting on many things and just looked through the photos from last year’s Bellingham Brain Cancer WALK (BBCW), and am smiling and crying at the same time.

Read More
May 29, 2020
2020 National HOPE Award – A Message From Our President

I am spending my day reflecting on the national brain tumor community.  Specifically, I am also spending a lot of time over the last several weeks, amongst COVID-19, reflecting on the my late husband’s brain cancer journey and the last 18 years of co-founding and running the Chris Elliott Fund, now DBA EndBrainCancer Initiative.

Read More
June 27, 2019
Let’s Write a Book Together to Help Others!

Thank you so much for your interest in submitting your story for my collaborative book. Everything happens in our lives for a reason. If you hadn’t gone through what you did, how would your life be different? What are you doing today to help others because of it? How can you use your past experience to help others?  

Read More
1 2 3

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram